Follow
Alex Louie
Alex Louie
Sunnybrook Health Sciences Centre
Verified email at sunnybrook.ca - Homepage
Title
Cited by
Cited by
Year
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
The Lancet 393 (10185), 2051-2058, 2019
15992019
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ...
The lancet oncology 16 (6), 630-637, 2015
15692015
Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: long-term results of a multi-institutional …
DR Gomez, C Tang, J Zhang, GR Blumenschein Jr, M Hernandez, JJ Lee, ...
Journal of Clinical Oncology 37 (18), 1558, 2019
10562019
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic …
DR Gomez, GR Blumenschein, JJ Lee, M Hernandez, R Ye, DR Camidge, ...
The lancet oncology 17 (12), 1672-1682, 2016
10122016
Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial
DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
Journal of Clinical Oncology 38 (25), 2830, 2020
8662020
Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke
DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ...
American journal of preventive medicine 20 (2), 16-66, 2001
3352001
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ...
BMC cancer 19, 1-15, 2019
1922019
Detection of local cancer recurrence after stereotactic ablative radiation therapy for lung cancer: physician performance versus radiomic assessment
SA Mattonen, DA Palma, C Johnson, AV Louie, M Landis, G Rodrigues, ...
International Journal of Radiation Oncology* Biology* Physics 94 (5), 1121-1128, 2016
1622016
Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)
S Siva, AV Louie, A Warner, A Muacevic, S Gandhidasan, L Ponsky, ...
Cancer 124 (5), 934-942, 2018
1582018
Inter-observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era
AV Louie, G Rodrigues, J Olsthoorn, D Palma, E Yu, B Yaremko, B Ahmad, ...
Radiotherapy and Oncology 95 (2), 166-171, 2010
1442010
Management of metastatic clear cell renal cell carcinoma: ASCO guideline
WK Rathmell, RB Rumble, PJ Van Veldhuizen, H Al-Ahmadie, ...
Journal of Clinical Oncology 40 (25), 2957-2995, 2022
1342022
Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review
H Chen, S Senan, EJ Nossent, RG Boldt, A Warner, DA Palma, AV Louie
International Journal of Radiation Oncology* Biology* Physics 98 (3), 622-631, 2017
1322017
Post-treatment mortality after surgery and stereotactic body radiotherapy for early-stage non-small-cell lung cancer
WA Stokes, MR Bronsert, RA Meguid, MG Blum, BL Jones, M Koshy, ...
J Clin Oncol 36 (7), 642-651, 2018
1312018
Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons
AV Louie, DA Palma, M Dahele, GB Rodrigues, S Senan
Radiotherapy and Oncology 114 (2), 138-147, 2015
1302015
Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach
S Siva, G Kothari, A Muacevic, AV Louie, BJ Slotman, BS Teh, SS Lo
Nature Reviews Urology 14 (9), 549-563, 2017
1252017
Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): results of a randomized trial
DA Palma, RA Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, ...
International Journal of Radiation Oncology, Biology, Physics 102 (3), S3-S4, 2018
1182018
Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies
NG Zaorsky, EJ Lehrer, G Kothari, AV Louie, S Siva
European urology oncology 2 (5), 515-523, 2019
1132019
Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes
S Harrow, DA Palma, R Olson, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
International Journal of Radiation Oncology* Biology* Physics 114 (4), 611-616, 2022
1062022
The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis
RJM Correa, AV Louie, NG Zaorsky, EJ Lehrer, R Ellis, L Ponsky, I Kaplan, ...
European urology focus 5 (6), 958-969, 2019
1062019
Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of propensity score studies
H Chen, JM Laba, RG Boldt, CD Goodman, DA Palma, S Senan, ...
International Journal of Radiation Oncology* Biology* Physics 101 (1), 186-194, 2018
1052018
The system can't perform the operation now. Try again later.
Articles 1–20